simendan has been researched along with cilostazol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Kherbetawy, MK; Makary, S; Tawfik, MK | 1 |
1 other study(ies) available for simendan and cilostazol
Article | Year |
---|---|
Cardioprotective and Anti-Aggregatory Effects of Levosimendan on Isoproterenol-Induced Myocardial Injury in High-Fat-Fed Rats Involves Modulation of PI3K/Akt/mTOR Signaling Pathway and Inhibition of Apoptosis: Comparison to Cilostazol.
Topics: Animals; Apoptosis; Cilostazol; Diet, High-Fat; Disease Models, Animal; Heart Rate; Inflammation Mediators; Isoproterenol; Lipids; Myocardial Infarction; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Simendan; TOR Serine-Threonine Kinases | 2018 |